BAY 63–2521, an oral soluble guanylate cyclase stimulator, has a favourable safety profile, improves cardiopulmonary haemodynamics and has therapeutic potential in pulmonary hypertension
✍ Scribed by Ardeschir Hossein Ghofrani; Gerrit Weimann; Reiner Frey; Robert Voswinckel; Melanie Thamm; Desire Bölkow; Norbert Weissmann; Wolfgang Mück; Sigrun Unger; Georg Wensing; Ralph Theo Schermuly; Friedrich Grimminger
- Publisher
- BioMed Central
- Year
- 2007
- Tongue
- English
- Weight
- 410 KB
- Volume
- 7
- Category
- Article
- ISSN
- 1471-2210
No coin nor oath required. For personal study only.
✦ Synopsis
Publish with Bio Med Central and every scientist can read your work free of charge "BioMed Central will be the most significant development for disseminating the results of biomedical researc h in our lifetime.
📜 SIMILAR VOLUMES
Publish with Bio Med Central and every scientist can read your work free of charge "BioMed Central will be the most significant development for disseminating the results of biomedical researc h in our lifetime.